Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin
Autor(a) principal: | |
---|---|
Data de Publicação: | 2013 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10400.7/474 |
Resumo: | Oxidized cell-free hemoglobin (Hb), including covalently cross-linked Hb multimers, is present in advanced atherosclerotic lesions. Oxidation of Hb produces methemoglobin (Fe(3+)) and ferryl hemoglobin (Fe(4+) = O(2-)). Ferryl iron is unstable and can return to the Fe(3+) state by reacting with specific amino acids of the globin chains. In these reactions globin radicals are produced followed by termination reactions yielding covalently cross-linked Hb multimers. Despite the evanescent nature of the ferryl state, herein we refer to this oxidized Hb as "ferryl Hb." Our aim in this work was to study formation and biological effects of ferrylHb. We demonstrate that ferrylHb, like metHb, can release its heme group, leading to sensitization of endothelial cells (ECs) to oxidant-mediated killing and to oxidation of low-density lipoprotein (LDL). Furthermore, we observed that both oxidized LDL and lipids derived from human atherosclerotic lesions trigger Hb oxidation and subsequent production of covalently cross-linked ferrylHb multimers. Previously we showed that ferrylHb disrupts EC monolayer integrity and induces expression of inflammatory cell adhesion molecules. Here we show that when exposed to ferrylHb, EC monolayers exhibit increased permeability and enhanced monocyte adhesion. Taken together, interactions between cell-free Hb and atheroma lipids engage in a vicious cycle, amplifying oxidation of plaque lipids and Hb. These processes trigger EC activation and cytotoxicity. |
id |
RCAP_11ee66008c3c722c109d7b6c990b79a8 |
---|---|
oai_identifier_str |
oai:arca.igc.gulbenkian.pt:10400.7/474 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl HemoglobinAtherosclerosisInflammation MediatorsFerritinsHemoglobinsOxidized cell-free hemoglobin (Hb), including covalently cross-linked Hb multimers, is present in advanced atherosclerotic lesions. Oxidation of Hb produces methemoglobin (Fe(3+)) and ferryl hemoglobin (Fe(4+) = O(2-)). Ferryl iron is unstable and can return to the Fe(3+) state by reacting with specific amino acids of the globin chains. In these reactions globin radicals are produced followed by termination reactions yielding covalently cross-linked Hb multimers. Despite the evanescent nature of the ferryl state, herein we refer to this oxidized Hb as "ferryl Hb." Our aim in this work was to study formation and biological effects of ferrylHb. We demonstrate that ferrylHb, like metHb, can release its heme group, leading to sensitization of endothelial cells (ECs) to oxidant-mediated killing and to oxidation of low-density lipoprotein (LDL). Furthermore, we observed that both oxidized LDL and lipids derived from human atherosclerotic lesions trigger Hb oxidation and subsequent production of covalently cross-linked ferrylHb multimers. Previously we showed that ferrylHb disrupts EC monolayer integrity and induces expression of inflammatory cell adhesion molecules. Here we show that when exposed to ferrylHb, EC monolayers exhibit increased permeability and enhanced monocyte adhesion. Taken together, interactions between cell-free Hb and atheroma lipids engage in a vicious cycle, amplifying oxidation of plaque lipids and Hb. These processes trigger EC activation and cytotoxicity.Hungarian Academy of Sciences, Hungarian Government Grants: (OTKA-K75883, OTKAK83478, OTKA- PD83435), European Union and the European Social Fund: (T´AMOP-4.2.2.A-11/1/KONV-2012-0045 and T´AMOP-4.2.2/B-10/1-2010-0024).Hindawi Publishing CorporationARCAPotor, LászlóBányai, EmeseBecs, GergelySoares, Miguel P.Balla, GyörgyBalla, JózsefJeney, Viktória2015-11-06T17:04:13Z2013-04-232013-04-23T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.7/474engLászló Potor, Emese Bányai, Gergely Becs, et al., “Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 676425, 13 pages, 2013. doi:10.1155/2013/67642510.1155/2013/676425info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-11-29T14:34:51Zoai:arca.igc.gulbenkian.pt:10400.7/474Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:11:45.004508Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
title |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
spellingShingle |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin Potor, László Atherosclerosis Inflammation Mediators Ferritins Hemoglobins |
title_short |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
title_full |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
title_fullStr |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
title_full_unstemmed |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
title_sort |
Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin |
author |
Potor, László |
author_facet |
Potor, László Bányai, Emese Becs, Gergely Soares, Miguel P. Balla, György Balla, József Jeney, Viktória |
author_role |
author |
author2 |
Bányai, Emese Becs, Gergely Soares, Miguel P. Balla, György Balla, József Jeney, Viktória |
author2_role |
author author author author author author |
dc.contributor.none.fl_str_mv |
ARCA |
dc.contributor.author.fl_str_mv |
Potor, László Bányai, Emese Becs, Gergely Soares, Miguel P. Balla, György Balla, József Jeney, Viktória |
dc.subject.por.fl_str_mv |
Atherosclerosis Inflammation Mediators Ferritins Hemoglobins |
topic |
Atherosclerosis Inflammation Mediators Ferritins Hemoglobins |
description |
Oxidized cell-free hemoglobin (Hb), including covalently cross-linked Hb multimers, is present in advanced atherosclerotic lesions. Oxidation of Hb produces methemoglobin (Fe(3+)) and ferryl hemoglobin (Fe(4+) = O(2-)). Ferryl iron is unstable and can return to the Fe(3+) state by reacting with specific amino acids of the globin chains. In these reactions globin radicals are produced followed by termination reactions yielding covalently cross-linked Hb multimers. Despite the evanescent nature of the ferryl state, herein we refer to this oxidized Hb as "ferryl Hb." Our aim in this work was to study formation and biological effects of ferrylHb. We demonstrate that ferrylHb, like metHb, can release its heme group, leading to sensitization of endothelial cells (ECs) to oxidant-mediated killing and to oxidation of low-density lipoprotein (LDL). Furthermore, we observed that both oxidized LDL and lipids derived from human atherosclerotic lesions trigger Hb oxidation and subsequent production of covalently cross-linked ferrylHb multimers. Previously we showed that ferrylHb disrupts EC monolayer integrity and induces expression of inflammatory cell adhesion molecules. Here we show that when exposed to ferrylHb, EC monolayers exhibit increased permeability and enhanced monocyte adhesion. Taken together, interactions between cell-free Hb and atheroma lipids engage in a vicious cycle, amplifying oxidation of plaque lipids and Hb. These processes trigger EC activation and cytotoxicity. |
publishDate |
2013 |
dc.date.none.fl_str_mv |
2013-04-23 2013-04-23T00:00:00Z 2015-11-06T17:04:13Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.7/474 |
url |
http://hdl.handle.net/10400.7/474 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
László Potor, Emese Bányai, Gergely Becs, et al., “Atherogenesis May Involve the Prooxidant and Proinflammatory Effects of Ferryl Hemoglobin,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 676425, 13 pages, 2013. doi:10.1155/2013/676425 10.1155/2013/676425 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
publisher.none.fl_str_mv |
Hindawi Publishing Corporation |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130572955582464 |